Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

iBio (IBIO) Cost of Revenue (2020 - 2022)

Historic Cost of Revenue for iBio (IBIO) over the last 4 years, with Q2 2022 value amounting to $15000.0.

  • iBio's Cost of Revenue fell 9197.86% to $15000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $216000.0, marking a year-over-year decrease of 7835.67%. This contributed to the annual value of $216000.0 for FY2022, which is 8522.57% down from last year.
  • As of Q2 2022, iBio's Cost of Revenue stood at $15000.0, which was down 9197.86% from $48000.0 recorded in Q1 2022.
  • iBio's Cost of Revenue's 5-year high stood at $493000.0 during Q1 2021, with a 5-year trough of $15000.0 in Q2 2022.
  • Moreover, its 3-year median value for Cost of Revenue was $110000.0 (2020), whereas its average is $159900.0.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 47325.58% in 2021, then crashed by 9197.86% in 2022.
  • iBio's Cost of Revenue (Quarter) stood at $211000.0 in 2020, then plummeted by 46.45% to $113000.0 in 2021, then tumbled by 86.73% to $15000.0 in 2022.
  • Its Cost of Revenue was $15000.0 in Q2 2022, compared to $48000.0 in Q1 2022 and $113000.0 in Q4 2021.